Article

Breast cancer survivors needed

Author(s):

It's been reported that more than half of survivors feel they didn't have all the information they needed to transition from treatment into survivorship. Many organizations are trying to address this need, especially as the population of survivors continues to grow. Army of Women is one organization that is tackling this issue by sponsoring a study to understand the best way to empower breast cancer survivors with the information they need. The "Pathways to Recovery After Breast Cancer" study is sponsored by the National Cancer Institute's Cancer Information Service and the Army of Women to find out the best way to provide post-treatment education. They are looking for 1000 participants, but only have about 600 registered, so if you want to help, here are the qualifications: •You were diagnosed with Stage I, II, or III breast cancer.•You have completed your primary breast cancer treatment within the last six months OR are about to complete treatment within the next month. "Primary" treatment includes surgery and/or chemotherapy and/or radiation. Although it is not required that you are taking any drugs, women who have completed or are about to complete primary treatment, but are taking Herceptin, Tamoxifen, and other such drugs, are eligible. •You have never been diagnosed with another cancer (breast cancer is the only invasive cancer you have had).•You are over 18 years old.•You are able to speak and understand English.•You live in the United States.•You have access to a computer. If you qualify, sign up here. And if you don't qualify but are interested in other studies, check out the "current studies" on the Army of Women website. Every little bit helps in the battle against cancer.

Related Videos
Photo credit: Max Mumby/Indigo via Getty Images
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
1 expert is featured in this series.
Dr. Stephanie Alice Baker
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
1 expert is featured in this series.
Related Content